Envisioning a Transformed Clinical Trials Enterprise in the United States:

Envisioning a Transformed Clinical Trials Enterprise in the United States:

Establishing an Agenda for 2020: Workshop Summary (2012)

Paperback
232 pages | 6 x 9
978-0-309-25315-4

Get the book now

STATUS » FINAL
Paperback
232 pages | 6 x 9
978-0-309-25315-4

Envisioning a Transformed Clinical Trials Enterprise in the United States:

Establishing an Agenda for 2020: Workshop Summary (2012)

  • Overview
  • Table of Contents
  • Related Resources

Authors

Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine

Suggested Citation

Institute of Medicine. Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary. Washington, DC: The National Academies Press, 2012.

Import this citation to:



ALSO OF INTEREST